BR112014001551A2 - derivados de indeno para uso no tratamento de doença inflamatória do intestino - Google Patents
derivados de indeno para uso no tratamento de doença inflamatória do intestinoInfo
- Publication number
- BR112014001551A2 BR112014001551A2 BR112014001551A BR112014001551A BR112014001551A2 BR 112014001551 A2 BR112014001551 A2 BR 112014001551A2 BR 112014001551 A BR112014001551 A BR 112014001551A BR 112014001551 A BR112014001551 A BR 112014001551A BR 112014001551 A2 BR112014001551 A2 BR 112014001551A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- inflammatory bowel
- bowel disease
- indene derivatives
- indene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/19—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups having unsaturation outside the aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/17—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161510628P | 2011-07-22 | 2011-07-22 | |
| PCT/IE2012/000037 WO2013014659A1 (en) | 2011-07-22 | 2012-07-20 | Indene derivatives for use in the treatment of inflammatory bowel disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014001551A2 true BR112014001551A2 (pt) | 2017-06-13 |
Family
ID=46584089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014001551A BR112014001551A2 (pt) | 2011-07-22 | 2012-07-20 | derivados de indeno para uso no tratamento de doença inflamatória do intestino |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9586885B2 (enExample) |
| EP (1) | EP2734496A1 (enExample) |
| JP (1) | JP5898768B2 (enExample) |
| CN (1) | CN103764608B (enExample) |
| AU (1) | AU2012288404A1 (enExample) |
| BR (1) | BR112014001551A2 (enExample) |
| CA (1) | CA2839606A1 (enExample) |
| NZ (1) | NZ618936A (enExample) |
| RU (1) | RU2601307C2 (enExample) |
| TW (1) | TWI537246B (enExample) |
| WO (1) | WO2013014659A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013014660A1 (en) * | 2011-07-22 | 2013-01-31 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
| CN110426464B (zh) * | 2019-07-08 | 2022-03-04 | 苏州正济药业有限公司 | 一种葡甲胺中异构体的hplc检测方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR19990071978A (ko) * | 1995-12-06 | 1999-09-27 | 존 클라시 디렉턴 | 인단 다이머 화합물 및 그 약학적 용도 |
| DE19619036A1 (de) | 1996-04-30 | 1997-11-13 | Schering Ag | Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
| WO1998005327A1 (en) * | 1996-08-05 | 1998-02-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted aromatic compounds |
| AU1598899A (en) * | 1997-11-20 | 1999-06-15 | Children's Medical Center Corporation | Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhe and scours |
| US20020128256A1 (en) * | 1997-11-20 | 2002-09-12 | Carlo Brugnara | Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation |
| WO2001030781A2 (en) * | 1999-10-20 | 2001-05-03 | Tanabe Seiyaku Co., Ltd. | INHIBITORS OF αLβ2 MEDIATED CELL ADHESION |
| ES2359916T3 (es) | 2003-04-15 | 2011-05-30 | Aquinox Pharmaceuticals Inc. | Derivados de indeno como agentes farmacéuticos. |
| US7592461B2 (en) * | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| WO2013014660A1 (en) | 2011-07-22 | 2013-01-31 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
| US20150141523A1 (en) | 2012-05-24 | 2015-05-21 | Venantius Limited | Compounds for use in the treatment of autoimmune inflammatory disease |
| EP2855416A1 (en) | 2012-05-24 | 2015-04-08 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
-
2012
- 2012-07-20 EP EP12740702.1A patent/EP2734496A1/en not_active Withdrawn
- 2012-07-20 CA CA2839606A patent/CA2839606A1/en not_active Abandoned
- 2012-07-20 WO PCT/IE2012/000037 patent/WO2013014659A1/en not_active Ceased
- 2012-07-20 AU AU2012288404A patent/AU2012288404A1/en not_active Abandoned
- 2012-07-20 US US14/124,937 patent/US9586885B2/en not_active Expired - Fee Related
- 2012-07-20 RU RU2013155270/04A patent/RU2601307C2/ru not_active IP Right Cessation
- 2012-07-20 JP JP2014520787A patent/JP5898768B2/ja not_active Expired - Fee Related
- 2012-07-20 BR BR112014001551A patent/BR112014001551A2/pt not_active IP Right Cessation
- 2012-07-20 TW TW101126409A patent/TWI537246B/zh not_active IP Right Cessation
- 2012-07-20 NZ NZ618936A patent/NZ618936A/en not_active IP Right Cessation
- 2012-07-20 CN CN201280035083.7A patent/CN103764608B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014524921A (ja) | 2014-09-25 |
| WO2013014659A1 (en) | 2013-01-31 |
| CA2839606A1 (en) | 2013-01-31 |
| RU2013155270A (ru) | 2015-08-27 |
| CN103764608B (zh) | 2016-02-03 |
| US20140128466A1 (en) | 2014-05-08 |
| TW201311637A (zh) | 2013-03-16 |
| RU2601307C2 (ru) | 2016-11-10 |
| AU2012288404A1 (en) | 2014-01-09 |
| NZ618936A (en) | 2015-07-31 |
| HK1196597A1 (zh) | 2014-12-19 |
| JP5898768B2 (ja) | 2016-04-06 |
| EP2734496A1 (en) | 2014-05-28 |
| TWI537246B (zh) | 2016-06-11 |
| US9586885B2 (en) | 2017-03-07 |
| CN103764608A (zh) | 2014-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201600144B (it) | Nuovi derivati eterociclici e loro uso nel trattamento di disturbi neurologici | |
| CO6801774A2 (es) | Compuestos de benzotiazol y su uso farmacéutico | |
| PT2641596T (pt) | Utilização de derivados de 1,3-difenilprop-2-en-1-ona para tratamento de doenças hepáticas | |
| CO6801796A2 (es) | Composiciones de tratamiento de pozo de liberación retardada para uso en fluídos de tratamiento de pozo | |
| BR112014010175A2 (pt) | unidades de filtro, componentes e recursos destas e métodos de uso e construção | |
| BRPI0908026A2 (pt) | Métodos para o tratamento de doenças do intestino | |
| BR112013034055A2 (pt) | alcaftadina para uso no tratamento de urticária | |
| BR112014013843A2 (pt) | uso de dispositivos para o tratamento de doenças neurológicas | |
| CO7000778A2 (es) | Derivados de pirazolopiridina, su procedimiento de preparación y su uso terapéutico | |
| PT2838539T (pt) | Derivados estrogénicos para utilização no tratamento de distúrbios neurológicos. | |
| BR112015002706A2 (pt) | niclosamida e seus derivados para uso no tratamento de tumores sólidos | |
| DK2903629T3 (da) | Antistofkonjugat til anvendelse ved behandling af inflammatorisk tarmsygdom | |
| PT2768859T (pt) | Antagonistas de il17c para o tratamento de desordens inflamatórias | |
| BR112014002830A2 (pt) | fotossensibilizador para uso terapêutico | |
| GB2496688B (en) | Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases | |
| BR112015008908A2 (pt) | uso de ivermectina e seus derivados e método para desenhar e sintetizar novos derivados | |
| PL2718434T3 (pl) | Kompozycje i sposoby leczenia choroby trzewnej | |
| ZA201408059B (en) | Compositions and methods for the treatment of inflammatory bowel disease | |
| BR112014004297A2 (pt) | compostos para uso em reforço da coagulação | |
| BRPI0915905A2 (pt) | uso de derivados de pirimidilaminobenzamida para o tratamento de fibrose | |
| CO7061074A2 (es) | Composiciones de liberación controlada y métodos para su uso | |
| IT1402047B1 (it) | Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali | |
| HRP20180011T1 (hr) | Spojevi za uporabu u liječenju filariaza | |
| BR112014001551A2 (pt) | derivados de indeno para uso no tratamento de doença inflamatória do intestino | |
| CO7071125A2 (es) | Composiciones, síntesis y métodos para el uso de derivados de fenilcicloalquilmetilamino |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2520 DE 25/04/2019. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |